MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202541031189 A) filed by Rk Pharma Inc on March 29, 2025, for “ready-To-Use Injectable Formulations Of Ecubectedin”.
Inventors include Ravishanker Kovi; and Vure Prasad.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: “READY-TO-USE INJECTABLE FORMULATIONS OF ECUBECTEDIN” The present invention relates to ready to use injectable formulations of Ecubectedin. The invention makes it possible to administer Ecubectedin without the need for reconstitution. The liquid formulation comprises Ecubectedin and/ or its pharmaceutically acceptable salts and pharmaceutically acceptable excipients for parenteral administration. The present invention relates to injectable formulations of Ecubectedin, packaged into container systems such as ampoules, vials, syringes, cartridges, bottles, and bags. The present invention relates to dual or multi-chamber bags for the intravenous administration of Ecubectedin wherein it contains Ecubectedin ready-to-administer for parenteral administration. Formula 1
Disclaimer: Curated by HT Syndication.
